Home > Boards > US OTC > Biotechs >

Aequus Pharmaceuticals (AQSZF)

Add AQSZF Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 8/18/2020 11:18:01 AM - Followers: 16 - Board type: Free - Posts Today: 0


Update April 8, 2017
Aequus Pharma (AQS.V) (AQSZF)

Market-Cap: c$17 Million (US$12 Million)
Cash: c$5.1 Million << enough untill mid 2018
Price: $0.17

Shares out: 71 Million

>>>>>>NEW interview with Ceo // May, 2017<<<<<<


MUST WATCH to realize the mega potential here

Lots of new Product in-licensing on the way to drive this unknown gem to profitability quickly ( see chart below ):

AQSZF (MC US$ 15M) 2 Marketed Drugs + 3 close to Approval including a Potential Blockbuster = SUPER LIFETIME OPPORTUNITY -

This undiscovered low float rocket is definitely the cheapest Biotech Gem you can get at this time. This Stock has 10 bagger Potential easily with all the Big Drugs close to Market entry .Get some of this Goldmine before she gets discovered .Management alone holding over 16 Million shares Ceo bought 840k shares at 0.30 just a few days ago .GLTA

Presentation November 2016



AQS1301 topline results in 1Q

File for CDN approval of Topiramate XR in 1H 2017

File for CDN approval of Oxcarbazepine XR in 1H 2017

Additional Product acquisitions in 2017

Partnership for AQS1301 in 2017

Operational profitability estimated in 2017

Two products launches to date (Tacrolimus IR and Vistitan™)

3 long-acting, transdermal programs in development, on track to file NDA in 2018

Marketed Products:

Tacrolimus IR : Aequus initiated promotional efforts for tacrolimus IR in December, 2015 •Tacrolimus products currently account for ~30% of a $300 million immunosuppressive market in Canada •Aequus is promoting the first to market generic version of Prograf (tacrolimus IR)

Vistitan : Aequus initiated commercial activities in Q2 2016 for Vistitan (bimatoprost 0.03%) •The Canadian glaucoma market in 2014 was estimated to be over $137 million, of which prostaglandins remain one of the primary treatment options.

NDA Filing for AQS-1301:Expected 3Q2017 Expected Commercial License (If Bioequivalence demonstrated in Phase I, Registration Study may NOT be required for Approval of AQS1301)

AQS-1301, a transdermal aripiprazole product candidate in development for potential weekly use in the treatment of irritability associated with autistic disorder, bipolar I disorder, schizophrenia and major depressive disorder. The currently available dosage forms of aripiprazole (sold primarily under the trade name Abilify®) reached total worldwide sales of over $8 billion USD in 2014. A once-weekly transdermal patch has the potential to improve medication adherence and reduce the frequency of relapse.

Podcast: Aequus Pharmaceuticals CEO Doug Janzen on the low cost of drug commercialization in Canada


James West: Sure. Have you built a pharmaceutical company before, Doug?

Doug Janzen: I have. So I’ve been in this industry for 20 years. I was a banker, then I ran a therapeutic company called Cardiome Pharma; I built that from 50 million to over 1 billion at its peak, and exited after doing an $800 million license with Merck — still the largest license transaction in Canadian history.

James West: Sure. Let me ask that another way: how do you plan to get to – I mean, how many of these deals can you do a year?

Doug Janzen: We bought our commercial infrastructure last July, and since then we’ve launched two products and we’ve just licensed the two Supernus programs. Those four products, we think an aggregate can do $40 million, $45 million at peak sales.

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AQSZF News: Aequus Pharmaceuticals reports Q4 results 04/23/2021 05:16:06 AM
#236   And , a hunting we will go >>> ;-) molee 08/18/20 11:18:01 AM
#235   This DOG needs to hunt ... ;-) molee 07/22/20 12:11:49 PM
#234   Aequus Receives Positive Formulary Decision in British Columbia molee 01/16/20 09:33:20 AM
#233   I have sold out on my shares at Birch69696969 01/10/20 07:52:16 AM
#232   Aequus taking it on the chin lately ... :-( molee 01/09/20 02:48:18 PM
#231   Aequus and Medicom Healthcare Sign Exclusive Term Sheet molee 12/13/19 11:53:23 AM
#230   Aequus Highlights Study Indicating Vistitan as the Most molee 10/18/19 08:46:42 AM
#229   A Return to Revenue Growth - Aequus Provides molee 08/27/19 09:57:48 AM
#228   Aequus Signs Exclusive Distribution Agreement with Medicom Healthcare molee 07/29/19 08:47:57 AM
#227   One day this little acorn is going to Basil22 07/05/19 11:53:53 PM
#226   Aequus to supply Kensington Eye Institute with Zepto molee 05/23/19 09:03:11 AM
#225   A little disappointed to see this back down molee 05/10/19 02:15:55 PM
#224   Amazing business strategy. One or two more deals Basil22 04/15/19 07:13:00 PM
#223   What is the opinion of the investors here BesaoT35 04/04/19 04:24:52 PM
#222   Aequus Announces Public Offering of Convertible Debenture molee 04/03/19 10:39:50 AM
#221   Halted .... For news ??? molee 04/03/19 09:56:35 AM
#220   $AQSZF looking stronger lately ... ;-) molee 01/28/19 10:45:09 AM
#219   This stock will ONLY MOVES once consistent news Chaka 01/16/19 06:31:27 AM
#218   Next year before they have great earnings. Idk Birch69696969 01/04/19 05:42:17 AM
#217   What has happened to this great opportunity ?? molee 12/21/18 12:03:20 PM
#216   We have a runner >>>>> Aequus Reports Largest molee 11/30/18 08:58:57 AM
#215   I agree!! Basil22 11/09/18 08:59:36 PM
#214   I am still here.. Chaka 11/09/18 04:48:11 AM
#213   Smart company move to create an advisory board for Basil22 11/05/18 09:07:03 AM
#212   Great interview supports why they have a great Basil22 10/22/18 10:17:49 PM
#211   Fully agree. GLTA GW greenwillow 09/04/18 01:20:56 PM
#210   Awesome company led by a smart CEO with Basil22 09/03/18 07:03:11 PM
#209   Aequus Reports 5th Consecutive Quarter of Revenue Growth molee 08/27/18 08:51:31 AM
#208   Aequus Announces Expansion of Market Opportunity for its molee 07/19/18 09:49:18 AM
#207   Aequus and Corium Join Forces to Advance Anti-Nausea molee 06/21/18 09:23:29 AM
#206   Aequus Announces First Canadian Cataract Procedures Using Zepto molee 06/18/18 09:06:27 AM
#205   Aequus Provides First Quarter 2018 Financial and Corporate Highlights molee 05/31/18 10:09:13 AM
#203   How big of a market for this product? Chaka 05/17/18 04:11:50 AM
#202   Aequus Announces Official Launch of Zepto Capsulotomy System molee 05/16/18 09:45:10 AM
#201   Sell the news again ? Can't seem to molee 05/04/18 10:07:17 AM
#200   SUPER NEWS!!! notshakenorstirred 05/03/18 06:11:44 PM
#199   Aequus Receives Positive FDA Regulatory Guidance for Anti-Nausea Patch molee 05/03/18 10:05:30 AM
#198   Super news, for the soon to explode, Canadian notshakenorstirred 04/27/18 07:05:23 PM
#197   No problem! Chaka 03/21/18 04:08:11 AM
#196   Great article, Chaka, thanks for posting! notshakenorstirred 03/19/18 09:11:05 PM
#195   NEWS OUT! Chaka 03/19/18 08:52:42 AM
#194   In time this "fledgling" will take flight.....and soar!!! notshakenorstirred 03/17/18 07:43:37 PM
#193   WOW! GIGANTIC ARTICLE INDEED! Chaka 03/14/18 03:31:17 AM
#192   A must Read! The Biggest Biotech Trends Analysts notshakenorstirred 03/13/18 05:33:44 PM
#190   $AQSZF on the move again ...... molee 02/16/18 10:53:30 AM
#189   Taking a bit of a bath here as molee 02/02/18 02:40:22 PM
#188   Aequus and Camargo Prepare for Meeting with FDA molee 01/31/18 09:33:27 AM
#187   CannaRoyalty and Aequus Pharmaceuticals Announce Joint Venture to molee 01/11/18 07:48:31 AM
#186   Coulda shoulda woulda. Thought about this a chainma1l 01/03/18 10:13:45 AM
#185   watch this bad boy run!! TrendTrade2016 01/03/18 06:08:59 AM
Consent Preferences